Global Contraceptive Market to Reach ~US$ 33,529 Mn by 2029
The global contraceptive market is projected to reach ~US$ 33,529 Mn by the end of 2029. The market was valued at ~US$ 18,373 Mn in 2019. If these figures hold true, the market will exhibit a CAGR of ~6.2% between 2019 and 2029. Regionally, North America is expected dominate the market. However during the forecast period, East Asia will exhibit more lucrative growth opportunities. In terms of product type, the market can be classified into contraceptive drugs and contraceptive devices. The contraceptives devices hold the major market share as compared to contraceptive devices.
Male Contraceptive Market to Witness High Growth
The contraceptive market is primarily driven by female category which holds the highest market share in 2019. However, the male segment is expected to grow at fastest CAGR during the forecast owing to growing usage of condoms. Furthermore, pharmaceutical companies are coming up with new innovative drugs or devices which will fuel the male contraceptive market with high growth rate.
Most of the devices and drugs are produced for female, along with a small portion of male. The companies are now trying to come up with male contraceptive pill which not only reduces the pregnancy occurrences, but also will change the way society think.
By Product Type
- Contraceptive Drugs
- Oral Contraceptive Pills
- Injectables
- Topical
Contraceptive Devices
- Diaphgrams
- Sponges
- Vaginal Rings
- Subdermal Implants
- Intrauterine Device
- Condom
- Male
- Female
By Gender
- Male
- Female
By Price Range
- High Range
- Low / Economy Range
By Sales Channel
- Wholesaler/ Distributor
- Hypermarket/ Supermarket
- Specialty Stores
- Drug & Pharma Stores
- Convenience Stores
- Online
- Others (hospitals, clinics etc.)
How will Growth Unfold?
Contraceptive market is primarily dominated by North America market owing to the government’s efforts encouraging the usage of contraceptive methods. The government of U.S. has supported the efforts of global Family Planning and Reproductive Health (FP/RH). Moreover, constant development of new contraceptive products push the North American contraceptive market for higher sales. Key companies are increasing their investments in research and development activities for the discovery of new formulation and products.
The North America market holds major value share in the global footprint followed by Europe due to high product awareness, and high adoption of contraceptive products. Developing regions such as East Asia and South Asia are also expanding at higher CAGR. East Asia is anticipated to grow at highest CAGR during the forecast owing to the presence of high contraception related medical needs coupled with rising user awareness levels and disposable incomes.
Moreover, new innovation in contraceptive drugs and devices will also boost the contraceptive market to a new height. Online sales are expected to grow with high CAGR during the forecast and will contribute a significant revenue share to the global contraceptive market.
Market segmentation
The global contraceptive market is segmented in detail to cover every aspect of the market and present complete market intelligence to readers.
Product Type
- Contraceptive Drugs
- Oral Contraceptive Pills
- Injectables
- Topical
- Contraceptive Devices
- Diaphgrams
- Sponges
- Vaginal Rings
- Subdermal Implants
- Intrauterine Device
- Condom
Gender
- Male
- Female
Price Range
- High Range
- Low / Economy Range
Sales Channel
- Wholesaler/ Distributor
- Hypermarket/ Supermarket
- Specialty Stores
- Drug & Pharma Stores
- Convenience Stores
- Online
- Others (hospitals, clinics etc.)
Region
- North America
- Latin America
- Europe
- East Asia
- South Asia
- Oceania
- Middle East & Africa
Need specific information?
In the news
by - Sudip Saha, Managing Director and Co-Founder of Future Market Insights
Our Clients
View Our Reports from Healthcare
View Reports